Volatile anesthetics and second messengers in cardiac tissue.
Vulliemoz
Y
Y
Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
D000777:Anesthetics / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D016718:Arachidonic Acid / Q000378:metabolism; D003864:Depression, Chemical; D019204:GTP-Binding Proteins / Q000378:metabolism; D006221:Halothane / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D007530:Isoflurane / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D015290:Second Messenger Systems / Q000187:drug effects*; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D000777:Anesthetics; D000889:Anti-Arrhythmia Agents; D010716:Phosphatidylinositols; D010743:Phospholipids; D010566:Virulence Factors, Bordetella; D016718:Arachidonic Acid; D007530:Isoflurane; D019204:GTP-Binding Proteins; D006221:Halothane